Brief: Organogenesis Q4 Net Product Revenue USD 225.1 Million
26/02/2026 21:05
Feb 26 (Reuters) - Organogenesis Q4 operating income USD 63.3 million. Q4 net income USD 43.7 million Q4 adjusted EBITDA USD 84.2 million Q4 adjusted net income USD 52.9 million
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers